BioSpace News Archive

EpicentRx Inc. (“EpicentRx”), is pleased to announce that it has been awarded a $500,000 Therapeutics RFP grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), to study potential neuroprotective effects of its lead small molecule, RRx-001 in Parkinson’s disease (PD).

Braintale, a medtech deciphering white matter, spin off from the Paris Greater Hospitals has been selected for an oral presentation of its abstract during the annual meeting of the European Society of Radiology held in Vienna from July 13th to July 17th 2022, demonstrating the technical advances of its digital biomarker platform and its usage in clinical settings.

The U.S. Food and Drug Administration issued warning letters to four companies for illegally selling honey-based products that may pose a significant health risk to consumers.

Provepharm, a French company with operations in the United States of America, specializing in the development of pharmaceutical applications, today announced that it has received FDA New Drug Approval for the marketing of its injectable BLUDIGO™ (Indigotindisulfonate Sodium) Injection.

The global Adenosine Triphosphate (ATP) Test Kit market size is estimated to be worth US$ 196.5 million in 2021 and is forecast to a readjusted size of US$ 359.4 million by 2030 with a CAGR of 8.9% during the forecast period 2022-2030.

A recent report provides crucial insights along with application based and forecast information in the Global Alvimopan Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market.

The global Piperacillin Sodium market size is estimated to be worth US$ 199 million in 2021 and is forecast to a readjusted size of US$ 250.7 million by 2030 with a CAGR of 3.3% during the forecast period 2022-2030.

The global Hepatitis B Vaccines market size is estimated to be worth US$ 1021.8 million in 2021 and is forecast to a readjusted size of US$ 1159.5 million by 2030 with a CAGR of 1.8% during the forecast period 2022-2030.

The global C-MET & HGF Inhibitors market size is estimated to be worth US$ 2294.7 million in 2021 and is forecast to a readjusted size of US$ 10450 million by 2030 with a CAGR of 23.9% during the forecast period 2022-2030.

The global Pharmaceutical Ethanol market size is estimated to be worth US$ 1224 million in 2021 and is forecast to a readjusted size of US$ 1091.8 million by 2030 with a CAGR of -1.6% during the forecast period 2022-2030.